Tango Therapeutics, Inc. · NASDAQ:TNGX

Crystal Adam sold 27,000 Tango Therapeutics, Inc. shares (Form 4)

Traded Apr 1, 2026 · Filed Apr 2, 2026

On Apr 1, 2026, Crystal Adam (President, R&D) sold 27,000 Tango Therapeutics, Inc. shares at US$21.20 for US$572K under a trading plan, leaving 112,622 shares. Filed Apr 2, 2026 (Form 4).

Sold
27,000 shares
Price
US$21.20
Value
US$572K
Holding after
112,622 shares
Trading plan
Yes (Made under a plan set in advance)
Role
President, R&D

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 1, 2026Common StockOption exercise27,000US$5.20139,622Direct
Apr 1, 2026Common StockSale27,000US$21.20112,622Direct

Source

View original at SEC

Related